Skip to main content
Made possible by:
FirstWord
Share
Latest News on Biosimilars
Celltrion’s Truxima approved in Australia
(Apr 20 2018)
Read Article
FDA commissioner to drug middlemen: You're part of the problem
(Apr 19 2018)
Read Article
Four Canadian provinces add Erelzi (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
(Apr 19 2018)
Read Article
Drugmakers take unorthodox route to boosting biosimilars
(Apr 18 2018)
Read Article
FSS completes special audit on Samsung BioLogics
(Apr 15 2018)
Read Article
Investor Day Highlights Durability of Mylan’s Global Platform
(Apr 11 2018)
Read Article
Get more news
